115 related articles for article (PubMed ID: 17034947)
1. Expression analyses of 27 DNA repair genes in astrocytoma by TaqMan low-density array.
Jiang Z; Hu J; Li X; Jiang Y; Zhou W; Lu D
Neurosci Lett; 2006 Dec; 409(2):112-7. PubMed ID: 17034947
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of immune defense genes in pilocytic astrocytomas.
Huang H; Hara A; Homma T; Yonekawa Y; Ohgaki H
J Neuropathol Exp Neurol; 2005 Oct; 64(10):891-901. PubMed ID: 16215461
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays.
Huang H; Colella S; Kurrer M; Yonekawa Y; Kleihues P; Ohgaki H
Cancer Res; 2000 Dec; 60(24):6868-74. PubMed ID: 11156382
[TBL] [Abstract][Full Text] [Related]
4. Comparative analyses of relative ERCC3 and ERCC6 mRNA levels in gliomas and adjacent non-neoplastic brain.
Dabholkar MD; Berger MS; Vionnet JA; Overton L; Thompson C; Bostick-Bruton F; Yu JJ; Silber JR; Reed E
Mol Carcinog; 1996 Sep; 17(1):1-7. PubMed ID: 8876669
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene.
Nakamura M; Watanabe T; Yonekawa Y; Kleihues P; Ohgaki H
Carcinogenesis; 2001 Oct; 22(10):1715-9. PubMed ID: 11577014
[TBL] [Abstract][Full Text] [Related]
6. The relationship between polymorphisms of XRCC5 genes with astrocytoma prognosis in the Han Chinese population.
He X; Zhu X; Li L; Zhang J; Wu R; Zhang Y; Kang L; Yuan D; Jin T
Oncotarget; 2016 Dec; 7(51):85283-85290. PubMed ID: 27852033
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase is an independent predictor of shortened progression free survival in patients with low-grade diffuse astrocytomas.
Komine C; Watanabe T; Katayama Y; Yoshino A; Yokoyama T; Fukushima T
Brain Pathol; 2003 Apr; 13(2):176-84. PubMed ID: 12744471
[TBL] [Abstract][Full Text] [Related]
8. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
9. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.
Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C
J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation-mediated down-regulation of CXCL12 in human astrocytoma.
Zhou W; Jiang Z; Song X; Liu Y; Wen P; Guo Y; Xu F; Kong L; Zhang P; Han A; Yu J
J Neurosci Res; 2008 Oct; 86(13):3002-10. PubMed ID: 18512766
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction.
van den Boom J; Wolter M; Blaschke B; Knobbe CB; Reifenberger G
Int J Cancer; 2006 Nov; 119(10):2330-8. PubMed ID: 16865689
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein Genes are Highly Expressed in Malignant Astrocytomas and Associated with Patient Survival.
Masiulionytė B; Valiulytė I; Tamašauskas A; Skiriutė D
Sci Rep; 2019 Apr; 9(1):5406. PubMed ID: 30932010
[TBL] [Abstract][Full Text] [Related]
13. Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts.
Jones DT; Mulholland SA; Pearson DM; Malley DS; Openshaw SW; Lambert SR; Liu L; Bäcklund LM; Ichimura K; Collins VP
Acta Neuropathol; 2011 Jun; 121(6):753-61. PubMed ID: 21327941
[TBL] [Abstract][Full Text] [Related]
14. Genomic copy number changes of DNA repair genes ERCC1 and ERCC2 in human gliomas.
Liang BC; Ross DA; Reed E
J Neurooncol; 1995 Oct; 26(1):17-23. PubMed ID: 8583241
[TBL] [Abstract][Full Text] [Related]
15. Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis.
MacDonald TJ; Pollack IF; Okada H; Bhattacharya S; Lyons-Weiler J
Methods Mol Biol; 2007; 377():203-22. PubMed ID: 17634619
[TBL] [Abstract][Full Text] [Related]
16. Relationship between SATB1 expression and prognosis in astrocytoma.
Chu SH; Ma YB; Feng DF; Zhang H; Qiu JH; Zhu ZA; Li ZQ; Jiang PC
J Clin Neurosci; 2013 Apr; 20(4):543-7. PubMed ID: 23317753
[TBL] [Abstract][Full Text] [Related]
17. Expression signatures of DNA repair genes correlate with survival prognosis of astrocytoma patients.
de Sousa JF; Torrieri R; Serafim RB; Di Cristofaro LF; Escanfella FD; Ribeiro R; Zanette DL; Paçó-Larson ML; da Silva WA; Tirapelli DP; Neder L; Carlotti CG; Valente V
Tumour Biol; 2017 Apr; 39(4):1010428317694552. PubMed ID: 28378638
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
[TBL] [Abstract][Full Text] [Related]
19. IGFBP2 is overexpressed by pediatric malignant astrocytomas and induces the repair enzyme DNA-PK.
Becher OJ; Peterson KM; Khatua S; Santi MR; MacDonald TJ
J Child Neurol; 2008 Oct; 23(10):1205-13. PubMed ID: 18952587
[TBL] [Abstract][Full Text] [Related]
20. [IDH1 mutation and MGMT expression in astrocytoma and the relationship with prognosis after radiotherapy].
Jiang M; Dong X; Li J; Li J; Qi J
Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):668-72. PubMed ID: 25567592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
